NTG CLARITY NETWORKS INC (NCI.CA) Fundamental Analysis & Valuation

TSX-V:NCI • CA62940V2030

Current stock price

1.01 CAD
-0.02 (-1.94%)
Last:

This NCI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. NCI.CA Profitability Analysis

1.1 Basic Checks

  • NCI had positive earnings in the past year.
  • In the past year NCI has reported a negative cash flow from operations.
  • Of the past 5 years NCI 4 years were profitable.
  • Each year in the past 5 years NCI had a positive operating cash flow.
NCI.CA Yearly Net Income VS EBIT VS OCF VS FCFNCI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • With an excellent Return On Assets value of 17.08%, NCI belongs to the best of the industry, outperforming 90.14% of the companies in the same industry.
  • NCI has a better Return On Equity (28.01%) than 92.96% of its industry peers.
  • NCI has a better Return On Invested Capital (23.79%) than 95.77% of its industry peers.
Industry RankSector Rank
ROA 17.08%
ROE 28.01%
ROIC 23.79%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCI.CA Yearly ROA, ROE, ROICNCI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

  • NCI has a better Profit Margin (9.85%) than 80.28% of its industry peers.
  • NCI's Profit Margin has improved in the last couple of years.
  • With a decent Operating Margin value of 13.86%, NCI is doing good in the industry, outperforming 77.46% of the companies in the same industry.
  • In the last couple of years the Operating Margin of NCI has declined.
  • With a Gross Margin value of 35.76%, NCI is not doing good in the industry: 60.56% of the companies in the same industry are doing better.
  • NCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.86%
PM (TTM) 9.85%
GM 35.76%
OM growth 3Y-3.27%
OM growth 5YN/A
PM growth 3Y14.92%
PM growth 5YN/A
GM growth 3Y-12.47%
GM growth 5Y7.3%
NCI.CA Yearly Profit, Operating, Gross MarginsNCI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

6

2. NCI.CA Health Analysis

2.1 Basic Checks

  • NCI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • NCI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NCI has more shares outstanding
  • The debt/assets ratio for NCI has been reduced compared to a year ago.
NCI.CA Yearly Shares OutstandingNCI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2023 2024 50M 100M
NCI.CA Yearly Total Debt VS Total AssetsNCI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • NCI has an Altman-Z score of 4.75. This indicates that NCI is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.75, NCI belongs to the top of the industry, outperforming 81.69% of the companies in the same industry.
  • A Debt/Equity ratio of 0.19 indicates that NCI is not too dependend on debt financing.
  • NCI has a Debt to Equity ratio of 0.19. This is comparable to the rest of the industry: NCI outperforms 57.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 4.75
ROIC/WACC2.42
WACC9.82%
NCI.CA Yearly LT Debt VS Equity VS FCFNCI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

  • A Current Ratio of 3.13 indicates that NCI has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.13, NCI is in the better half of the industry, outperforming 78.87% of the companies in the same industry.
  • A Quick Ratio of 3.13 indicates that NCI has no problem at all paying its short term obligations.
  • NCI's Quick ratio of 3.13 is amongst the best of the industry. NCI outperforms 80.28% of its industry peers.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3.13
NCI.CA Yearly Current Assets VS Current LiabilitesNCI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M

8

3. NCI.CA Growth Analysis

3.1 Past

  • NCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.26%, which is quite good.
  • Measured over the past years, NCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 68.04% on average per year.
  • The Revenue has grown by 62.61% in the past year. This is a very strong growth!
  • Measured over the past years, NCI shows a very strong growth in Revenue. The Revenue has been growing by 45.43% on average per year.
EPS 1Y (TTM)15.26%
EPS 3Y68.04%
EPS 5YN/A
EPS Q2Q%-15.85%
Revenue 1Y (TTM)62.61%
Revenue growth 3Y67.72%
Revenue growth 5Y45.43%
Sales Q2Q%42.22%

3.2 Future

  • Based on estimates for the next years, NCI will show a small growth in Earnings Per Share. The EPS will grow by 7.62% on average per year.
  • The Revenue is expected to grow by 26.70% on average over the next years. This is a very strong growth
EPS Next Y-29.54%
EPS Next 2Y-2.61%
EPS Next 3Y7.62%
EPS Next 5YN/A
Revenue Next Year45.61%
Revenue Next 2Y31.42%
Revenue Next 3Y26.7%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NCI.CA Yearly Revenue VS EstimatesNCI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
NCI.CA Yearly EPS VS EstimatesNCI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.05 0.1 0.15 0.2

6

4. NCI.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 7.21, the valuation of NCI can be described as very cheap.
  • Based on the Price/Earnings ratio, NCI is valued cheaper than 87.32% of the companies in the same industry.
  • NCI is valuated cheaply when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 5.60, the valuation of NCI can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, NCI is valued cheaper than 85.92% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.83. NCI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.21
Fwd PE 5.6
NCI.CA Price Earnings VS Forward Price EarningsNCI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NCI is valued cheaply inside the industry as 87.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.91
NCI.CA Per share dataNCI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • NCI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.61%
EPS Next 3Y7.62%

0

5. NCI.CA Dividend Analysis

5.1 Amount

  • No dividends for NCI!.
Industry RankSector Rank
Dividend Yield 0%

NCI.CA Fundamentals: All Metrics, Ratios and Statistics

NTG CLARITY NETWORKS INC

TSX-V:NCI (3/13/2026, 7:00:00 PM)

1.01

-0.02 (-1.94%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners0.22%
Inst Owner ChangeN/A
Ins Owners24.38%
Ins Owner ChangeN/A
Market Cap48.25M
Revenue(TTM)76.65M
Net Income(TTM)7.55M
Analysts85.45
Price Target3.67 (263.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-59.73%
Min EPS beat(2)-85.29%
Max EPS beat(2)-34.18%
EPS beat(4)1
Avg EPS beat(4)-14.44%
Min EPS beat(4)-85.29%
Max EPS beat(4)94.17%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.48%
Min Revenue beat(2)-5.69%
Max Revenue beat(2)0.73%
Revenue beat(4)3
Avg Revenue beat(4)1.13%
Min Revenue beat(4)-5.69%
Max Revenue beat(4)8.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.24%
PT rev (3m)-9.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)8.33%
EPS NY rev (3m)-35%
Revenue NQ rev (1m)-1.53%
Revenue NQ rev (3m)-1.38%
Revenue NY rev (1m)-0.71%
Revenue NY rev (3m)-0.71%
Valuation
Industry RankSector Rank
PE 7.21
Fwd PE 5.6
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 1.79
P/tB 2.06
EV/EBITDA 3.91
EPS(TTM)0.14
EY13.86%
EPS(NY)0.18
Fwd EY17.85%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS1.6
BVpS0.56
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.33
Profitability
Industry RankSector Rank
ROA 17.08%
ROE 28.01%
ROCE 33.04%
ROIC 23.79%
ROICexc 29.91%
ROICexgc 34.7%
OM 13.86%
PM (TTM) 9.85%
GM 35.76%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.27%
OM growth 5YN/A
PM growth 3Y14.92%
PM growth 5YN/A
GM growth 3Y-12.47%
GM growth 5Y7.3%
F-Score5
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA 0.43
Cap/Depr 101.9%
Cap/Sales 1.94%
Interest Coverage 31.2
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.13
Quick Ratio 3.13
Altman-Z 4.75
F-Score5
WACC9.82%
ROIC/WACC2.42
Cap/Depr(3y)274.99%
Cap/Depr(5y)720.23%
Cap/Sales(3y)6.12%
Cap/Sales(5y)8.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.26%
EPS 3Y68.04%
EPS 5YN/A
EPS Q2Q%-15.85%
EPS Next Y-29.54%
EPS Next 2Y-2.61%
EPS Next 3Y7.62%
EPS Next 5YN/A
Revenue 1Y (TTM)62.61%
Revenue growth 3Y67.72%
Revenue growth 5Y45.43%
Sales Q2Q%42.22%
Revenue Next Year45.61%
Revenue Next 2Y31.42%
Revenue Next 3Y26.7%
Revenue Next 5YN/A
EBIT growth 1Y53.89%
EBIT growth 3Y62.24%
EBIT growth 5YN/A
EBIT Next Year19.12%
EBIT Next 3Y25.69%
EBIT Next 5YN/A
FCF growth 1Y-1129.52%
FCF growth 3Y85.08%
FCF growth 5YN/A
OCF growth 1Y-287.68%
OCF growth 3Y12.61%
OCF growth 5Y234.98%

NTG CLARITY NETWORKS INC / NCI.CA Fundamental Analysis FAQ

What is the fundamental rating for NCI stock?

ChartMill assigns a fundamental rating of 6 / 10 to NCI.CA.


What is the valuation status for NCI stock?

ChartMill assigns a valuation rating of 6 / 10 to NTG CLARITY NETWORKS INC (NCI.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for NTG CLARITY NETWORKS INC?

NTG CLARITY NETWORKS INC (NCI.CA) has a profitability rating of 6 / 10.


What is the expected EPS growth for NTG CLARITY NETWORKS INC (NCI.CA) stock?

The Earnings per Share (EPS) of NTG CLARITY NETWORKS INC (NCI.CA) is expected to decline by -29.54% in the next year.